| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comment on the Sun et al trial 'Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: An open-label randomized controlled trial'
|
Kombathula, Sri Harsha
|
|
|
147 |
C |
p. 249
|
artikel
|
| 2 |
Authors’ response to Letter to the Editor “Don’t forget Arnhem”
|
Voskuilen, C.S.
|
|
|
147 |
C |
p. 237
|
artikel
|
| 3 |
Carbon ion radiotherapy in pancreatic cancer: A review of clinical data
|
Liermann, Jakob
|
|
|
147 |
C |
p. 145-150
|
artikel
|
| 4 |
Clinical and radiographic adverse events after Gamma Knife radiosurgery for brainstem lesions: A dosimetric analysis
|
Lehrer, Eric J.
|
|
|
147 |
C |
p. 200-209
|
artikel
|
| 5 |
Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer
|
Manzar, Gohar S.
|
|
|
147 |
C |
p. 64-74
|
artikel
|
| 6 |
Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial
|
van der Valk, Maxime J.M.
|
|
|
147 |
C |
p. 75-83
|
artikel
|
| 7 |
Contents
|
|
|
|
147 |
C |
p. v-vii
|
artikel
|
| 8 |
Corrigendum to “Contiguous pattern spreading in patients with Hodgkin’s disease” [Radiother. Oncol. 47 (1998) 7–16]
|
Ludwig Roth, Stephan
|
|
|
147 |
C |
p. 99
|
artikel
|
| 9 |
Deformable image registration uncertainty for inter-fractional dose accumulation of lung cancer proton therapy
|
Nenoff, Lena
|
|
|
147 |
C |
p. 178-185
|
artikel
|
| 10 |
3-Dimensional target coverage assessment for MRI guided esophageal cancer radiotherapy
|
Boekhoff, M.R.
|
|
|
147 |
C |
p. 1-7
|
artikel
|
| 11 |
Don’t forget Arnhem!
|
van der Steen-Banasik, Elzbieta M.
|
|
|
147 |
C |
p. 236
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
147 |
C |
p. ii
|
artikel
|
| 13 |
Efficacy and safety of stenting and additional oncological treatment versus stenting alone in unresectable esophageal cancer: A meta-analysis and systematic review
|
Tinusz, Benedek
|
|
|
147 |
C |
p. 169-177
|
artikel
|
| 14 |
Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy
|
van der Heijden, Martijn
|
|
|
147 |
C |
p. 186-194
|
artikel
|
| 15 |
Erratum to “Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial” [Radiother. Oncol. 147 (2020) 75–83]
|
van der Valk, Maxime J.M.
|
|
|
147 |
C |
p. e1
|
artikel
|
| 16 |
Exploring implementation of the ESTRO Core Curriculum at the national level
|
Giuliani, Meredith
|
|
|
147 |
C |
p. 118-122
|
artikel
|
| 17 |
How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19?
|
Wei, Wei
|
|
|
147 |
C |
p. 100-102
|
artikel
|
| 18 |
Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy
|
van Rijn-Dekker, Maria I.
|
|
|
147 |
C |
p. 103-110
|
artikel
|
| 19 |
Implementing an online radiotherapy quality assurance programme with supporting continuous medical education – report from the EMBRACE-II evaluation of cervix cancer IMRT contouring
|
Duke, Simon L.
|
|
|
147 |
C |
p. 22-29
|
artikel
|
| 20 |
In Regard to Fernando et al.: Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial
|
Gultekin, Melis
|
|
|
147 |
C |
p. 232
|
artikel
|
| 21 |
In response to Park, et al.
|
van Diessen, Judi N.A.
|
|
|
147 |
C |
p. 245-246
|
artikel
|
| 22 |
Is low dose radiation therapy a potential treatment for COVID-19 pneumonia?
|
Kirkby, Charles
|
|
|
147 |
C |
p. 221
|
artikel
|
| 23 |
Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable
|
Kirsch, David G.
|
|
|
147 |
C |
p. 217-220
|
artikel
|
| 24 |
Letter to the editor involving the article “A prospective, multi-centre trial of multi-parametric MRI as a biomarker in anal carcinoma”
|
Rojas-Rojas, María M.
|
|
|
147 |
C |
p. 238
|
artikel
|
| 25 |
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic
|
Magrini, Stefano Maria
|
|
|
147 |
C |
p. 229-230
|
artikel
|
| 26 |
Linear accelerator-based radiosurgery is associated with lower incidence of radionecrosis compared with gamma knife for treatment of multiple brain metastases
|
Sebastian, Nikhil T.
|
|
|
147 |
C |
p. 136-143
|
artikel
|
| 27 |
Local dose analysis to predict acute and late urinary toxicities after prostate cancer radiotherapy: Assessment of cohort and method effects
|
Mylona, Eugenia
|
|
|
147 |
C |
p. 40-49
|
artikel
|
| 28 |
Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS)
|
Dhawan, Gaurav
|
|
|
147 |
C |
p. 212-216
|
artikel
|
| 29 |
Low dose radiation therapy for COVID-19 pneumonia: A double-edged sword
|
Kefayat, Amirhosein
|
|
|
147 |
C |
p. 224-225
|
artikel
|
| 30 |
Methodological concerns for investigating the effects of mid-treatment break of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC)
|
Kibe, Yuichi
|
|
|
147 |
C |
p. 234
|
artikel
|
| 31 |
Multi-institutional dosimetric delivery assessment of intracranial stereotactic radiosurgery on different treatment platforms
|
Dimitriadis, Alexis
|
|
|
147 |
C |
p. 153-161
|
artikel
|
| 32 |
Perspectives on the model-based approach to proton therapy trials: A retrospective study of a lung cancer randomized trial
|
McNamara, Aimee L.
|
|
|
147 |
C |
p. 8-14
|
artikel
|
| 33 |
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
|
Troost, Esther G.C.
|
|
|
147 |
C |
p. 227-228
|
artikel
|
| 34 |
Prediction of radiation-induced mucositis of H&N cancer patients based on a large patient cohort
|
Hansen, C.R.
|
|
|
147 |
C |
p. 15-21
|
artikel
|
| 35 |
Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer
|
Draulans, Cédric
|
|
|
147 |
C |
p. 92-98
|
artikel
|
| 36 |
Professional quality of life and burnout amongst radiation oncologists: The impact of alexithymia and empathy
|
Franco, Pierfrancesco
|
|
|
147 |
C |
p. 162-168
|
artikel
|
| 37 |
Prognostic factors and patterns of recurrence after curative resection for patients with distal cholangiocarcinoma
|
Zhou, Weiwen
|
|
|
147 |
C |
p. 111-117
|
artikel
|
| 38 |
Prospective assessment of mask versus frame fixation during Gamma Knife treatment for brain metastases
|
Grimm, Mario A.
|
|
|
147 |
C |
p. 195-199
|
artikel
|
| 39 |
Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges
|
Beddok, Arnaud
|
|
|
147 |
C |
p. 30-39
|
artikel
|
| 40 |
Radiation therapy for COVID-19 pneumopathy
|
Trott, Klaus Rüdiger
|
|
|
147 |
C |
p. 210-211
|
artikel
|
| 41 |
Rates of rectal toxicity in patients treated with high dose rate brachytherapy as monotherapy compared to dose-escalated external beam radiation therapy for localized prostate cancer
|
Parzen, Jacob S.
|
|
|
147 |
C |
p. 123-129
|
artikel
|
| 42 |
Regarding: Van Diessen et al., “Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced non-small cell lung cancer (NSCLC) patients”
|
Park, Jongmoo
|
|
|
147 |
C |
p. 243-244
|
artikel
|
| 43 |
Reply to Srinivas Chilukuri et al: The toxicity data from POP-RT: Proving the “Obvious” and challenging the “Norm”
|
Murthy, Vedang
|
|
|
147 |
C |
p. 248
|
artikel
|
| 44 |
Response letter: Handling of COVID-19 positive lung cancer patients during the pandemic
|
Guckenberger, Matthias
|
|
|
147 |
C |
p. 231
|
artikel
|
| 45 |
Response to Gultekin et al. regarding SECRAB trial toxicity
|
Fernando, Indrajit N.
|
|
|
147 |
C |
p. 233
|
artikel
|
| 46 |
Response to Kibe Y et al. “Methodological concerns for investigating the effects of midtreatment break of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC)”
|
Jackson, W.C.
|
|
|
147 |
C |
p. 235
|
artikel
|
| 47 |
Response to Ling et al. regarding “An integrated physico-chemical approach for explaining the differential impact of FLASH versus conventional dose rate irradiation on cancer and normal tissue responses”
|
Buettner, Garry R.
|
|
|
147 |
C |
p. 241-242
|
artikel
|
| 48 |
Response to: Low dose radiation therapy for COVID-19 pneumonia a double-edged sword
|
Kirkby, Charles
|
|
|
147 |
C |
p. 226
|
artikel
|
| 49 |
Response to MM Rojas-Rojas et al
|
Jones, Michael
|
|
|
147 |
C |
p. 239
|
artikel
|
| 50 |
Results of the ACCEL trial: Dosimetry in accelerated partial breast irradiation
|
Quirk, Sarah
|
|
|
147 |
C |
p. 50-55
|
artikel
|
| 51 |
RILI model and the Covid-19 pneumonia: The radiation oncologist point of view
|
Lazzari, Grazia
|
|
|
147 |
C |
p. 222-223
|
artikel
|
| 52 |
Selection of a high-level physician may help improve outcomes of nasopharyngeal carcinoma
|
Fei, Zhaodong
|
|
|
147 |
C |
p. 130-135
|
artikel
|
| 53 |
Significant reduction of oncologic pulmonary death by local control for pulmonary oligometastases treated with stereotactic body radiotherapy
|
Yamamoto, Takaya
|
|
|
147 |
C |
p. 86-91
|
artikel
|
| 54 |
SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approach
|
de Veij Mestdagh, Pieter D.
|
|
|
147 |
C |
p. 56-63
|
artikel
|
| 55 |
The impact of Coronavirus (COVID-19) on head and neck cancer patients’ care
|
De Felice, Francesca
|
|
|
147 |
C |
p. 84-85
|
artikel
|
| 56 |
The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy: Asian perspectives in the immunotherapy era
|
So, Tsz-Him
|
|
|
147 |
C |
p. 144
|
artikel
|
| 57 |
The simulation-CT: Radiotherapy’s useful tool in the race against COVID-19 pandemic. A serendipity approach
|
Vitullo, Angelo
|
|
|
147 |
C |
p. 151-152
|
artikel
|
| 58 |
The toxicity data from POP-RT: Proving the “Obvious” and challenging the “Norm”
|
Chilukuri, Srinivas
|
|
|
147 |
C |
p. 247
|
artikel
|
| 59 |
To the Editors
|
Ling, C. Clifton
|
|
|
147 |
C |
p. 240
|
artikel
|
Tijdschrift beschrijving